More than 90% of clinical-trial compounds fail to demonstrate sufficient efficacy and safety. To mitigate this issue, many look to third-parties to conduct extensive research via systematic literature review (SLR) to gather the relevant information needed to validate the investment and approach to a trial. While providing valuable insight, each SLR can cost over $140,000.
SLRs are largely conducted via manual processes – with researchers needing to compile, review and analyze large sets of unstructured content. As a result, these processes are incredibly time consuming due to the amount of data and grey literature that needs to be consumed and reported on to make SLRs successful. Due to the nature of this work, insights can be missed and timelines can be delayed which hold up productivity for the end customer.
Advancements in deep learning text analytics are enhancing systematic literature reviews by improving the accessibility and searchability of unstructured content. Vyasa has developed high-performing deep learning models that understand context and can identify key terms that improve the accuracy and time spent on systematic literature reviews. We then take this a step further with our Layar data fabric, a novel data architecture that unifies content sources into a single platform. With the Vyasa platform, users can:
By leveraging Vyasa, users can improve query accuracy by 97% while reducing research times by as much as 90%, leading to smarter, more efficient systematic literature reviews.